Hopstem won the "Pharma BIG Star" 2021 Biological Innovation Drug Most Growth Annual Award
Hopstem was included in the list of 2022 Hangzhou Quasi-Unicorn Enterprises
Hopstem is honored to be on the list of "KPMG China's first 50 Biotechnology Innovation Enterprises"
Hopstem was listed in the China Future Healthcare Rankings 2022-Top 100 Biomedical Companies
Dr. Jing Fan from Hopstem was selected for the 2022 Forbes list “TOP50 Women in Science and Technology in China”
Hopstem was listed on the Excellent List and won the "Best Biomedical Company of the Year" award
The phase II GMP cell manufacturing center of Hopstem officially opened!
Hopstem won the "Pharma BIG Star" 2021 Biological Innovation Drug Most Growth Annual Award